Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tom J.P. Jansen"'
Autor:
Marti Boss, B.E. de Galan, Maarten Brom, S van Lith, Mijke Buitinga, M. van der Kolk, M. Stommel, Martin Gotthardt, Tom J.P. Jansen, Cathelijne Frielink, H. van Goor
Publikováno v:
59. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin.
Autor:
Marti Boss, Martin Béhé, Mijke Buitinga, Maarten Brom, Tom J.P. Jansen, Sanne A. M. van Lith, Lieke Joosten, Martin Gotthardt
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals
Journal of Labelled Compounds & Radiopharmaceuticals, 62, 10, pp. 656-672
Journal of Labelled Compounds & Radiopharmaceuticals, 62, 656-672
Journal of Labelled Compounds & Radiopharmaceuticals
Journal of Labelled Compounds & Radiopharmaceuticals, 62, 10, pp. 656-672
Journal of Labelled Compounds & Radiopharmaceuticals, 62, 656-672
Journal of Labelled Compounds & Radiopharmaceuticals
Insulinomas, neuroendocrine tumors arising from pancreatic beta cells, often show overexpression of the glucagon-like peptide-1 receptor. Therefore, imaging with glucagon-like peptide analog exendin-4 can be used for diagnosis and preoperative locali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2ee432db12e3d179fc3ba3fdc33beb8
https://lirias.kuleuven.be/handle/123456789/641829
https://lirias.kuleuven.be/handle/123456789/641829
Autor:
Tom J.P. Jansen, Damian Wild, Marti Boss, Marcel J.R. Janssen, Wietske Woliner-van der Weg, Inge van der Kroon, Martin Gotthardt, Eric P. Visser, Mijke Buitinga, Maarten Brom, Erik H.J.G. Aarntzen, Martin Béhé
Publikováno v:
The Journal of Nuclear Medicine (1978), 60, 812-816
Journal of Nuclear Medicine
The Journal of Nuclear Medicine (1978), 60, 6, pp. 812-816
Journal of Nuclear Medicine
The Journal of Nuclear Medicine (1978), 60, 6, pp. 812-816
Being highly expressed in insulinomas, the glucagon-like peptide-1 receptor (GLP-1R) is a potential target for diagnosis, localization and treatment with the radiolabeled GLP-1R agonist exendin. Tracer accumulation in the kidneys, however, hampers ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9f0b33853a84e5c78f57025d57eadef
https://lirias.kuleuven.be/handle/123456789/634079
https://lirias.kuleuven.be/handle/123456789/634079
Autor:
Miriam Cnop, Sanne A. M. van Lith, Martin Gotthardt, Dick Mul, Henk-Jan Aanstoot, Mijke Buitinga, Frank Martin, Decio L. Eizirik, Maarten Brom, Olle Korsgren, Marti Boss, Olof Eriksson, Tom J.P. Jansen
Publikováno v:
Diabetologia, 61, 12, pp. 2516-2519
Diabetologia, 61 (12
Diabetologia, 61, 2516-2519
Diabetologia, 61 (12
Diabetologia, 61, 2516-2519
In this issue of Diabetologia, Alavi and Werner (https://doi.org/10.1007/s00125-018-4676-1) criticise the attempts to use positron emission tomography (PET) for in vivo imaging of pancreatic beta cells, which they consider as ‘futile’. In support
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d8243a5120d7b6f4dd7b2bac3066fea
https://hdl.handle.net/2066/197942
https://hdl.handle.net/2066/197942
Publikováno v:
The Journal of Nuclear Medicine (1978), 61, 1, pp. 112-116
The Journal of Nuclear Medicine (1978), 61, 112-116
The Journal of Nuclear Medicine (1978), 61, 112-116
68Ga-NODAGA-exendin-4 is a promising tracer for β-cell imaging using PET/CT. Possible applications include preoperative visualization of insulinomas and discrimination between focal and diffuse forms of congenital hyperinsulinism. There is also a si